NEW YORK (GenomeWeb News) – Helicos BioSciences reported in a filing with the US Securities and Exchange Commission yesterday after the close of the market that its fourth-quarter grant revenues increased to $206,000 from $117,000 year over year.

The firm also reported its first ever product revenue, totaling $36,000 for the three-month period ended Dec. 31, 2008. The company said in the filing that it expects to "recognize revenue from one of our initial 2008 instrument shipments in 2009."

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers hope to tease out the signature effects that different carcinogens leave on the genome to determine their contributions to disease, Mosaic reports.

An Imperial College London-led team reports that it was able to use a gene drive to control a population of lab mosquitos.

The Wall Street Journal looks into the cost of new gene therapies.

In PNAS this week: genomic effects of silver fox domestication, limited effect of mitochondrial mutations on aging in fruit flies, and more.